Please select a Capability in order to start your service request.
Redefine staff productivity with a fully integrated, automated molecular platform
The BD MAX™ system offers you an efficient path to improved clinical outcomes by combining and automating extraction and thermocycling into a single platform capable of running both FDA-cleared and open system assays. Flexibility and standardization allow you to address the breadth of your testing needs.
The system features integrated and fully automated extraction and thermocycling steps.
Ease of use
The system is CLIA moderately complex and easy to use.
The system is capable of running both FDA-cleared and open system assays.
Used for in vitro diagnostic testing for direct, qualitative detection
|Assays available for BD MAX system|
|443418||BD MAX Cdiff assay||Clostridium difficile toxin B gene (tcdB) in human liquid or soft stool specimens|
|442963||BD MAX enteric bacterial panel||Detection and differentiation of enteric bacterial pathogens|
|442960||BD MAX enteric parasite panel||Direct detection of enteric parasitic pathogens|
|441772||BD MAX GBS assay||Group B Streptococcus (GBS) DNA in Lim broth cultures obtained from vaginal-rectal swab specimens from antepartum pregnant women|
|443461||BD MAX MRSA XT assay||Rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) DNA from nasal swabs|
|442999||BD MAX StaphSR assay||Direct detection and differentiation of Staphylococcus aureus (SA) and MRSA DNA from nasal swabs|
|443712||BD MAX vaginal panel assay||Direct detection of the three most common infectious cases of bacterial vaginosis, vulvovaginal candidiasis and trichomoniasis|
|443824||BD MAX CT/GC/TV assay||Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis|
The BD MAX system is cleared or approved by the U.S. FDA only when used with BD MAX™ IVD assays, which have been cleared or approved by the FDA. IVD assays, research use only (RUO) assays and user-defined protocols (UDP) cannot be combined in the same rack.